Meda AB denies any stake sale talks with Sun Pharmaceutical

06 Jun 2013 Evaluate

Swedish drug firm Meda AB has clarified that it is not in any discussions with Sun Pharmaceutical Industries for a $5 billion stake sale. Earlier, it was reported that Sun Pharmaceutical Industries, country’s third largest drug maker by sales, was in talks to acquire Meda AB in a deal potentially worth of about $5 billion. Further, it was also reported that letter of intent for acquisition was signed and due diligence process was soon to start and be completed within 6 months.

Sun Pharmaceuticals Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1783.25 -14.00 (-0.78%)
16-Dec-2025 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.25
Dr. Reddys Lab 1274.40
Cipla 1502.65
Zydus Lifesciences 920.80
Lupin 2083.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×